Article Information
- Received May 5, 2016
- Revision received April 30, 2018
- Accepted May 13, 2018
- First published May 23, 2018.
- Version of record published June 27, 2018.
Author Information
Author contributions
Author contributions: C.J.W. wrote the first draft of the paper; C.J.W., A.T., H.R., Q.D., Y.F.L., and D.M.S. edited the paper; C.J.W., A.T., H.R., Q.D., Y.F.L., and D.M.S. designed research; C.J.W., A.T., H.R., and T.G. performed research; T.G. and Q.D. contributed unpublished reagents/analytic tools; C.J.W., A.T., H.R., Y.F.L., and D.M.S. analyzed data; C.J.W., A.T., H.R., Y.F.L., and D.M.S. wrote the paper.
Disclosures
- Received May 5, 2016.
- Revision received April 30, 2018.
- Accepted May 13, 2018.
This work was supported by the National Science Foundation (Grant 1146944-IOS), the Purdue Research Foundation, and the Office of the Executive Vice President for Research and Partnerships, National Institutes of Health (NIH Targeted Initiative to D.M.S. and Grant R35GM119787 to Q.D.), and the Purdue Center for Cancer Research (NIH Grant P30CA023168 to Q.D.). Yuk Fai Leung was partially supported by a research grant from the International Retinal Research Foundation. We thank Brian A. Link for providing the Tg(ath5:GFP) transgenic line for this project, Tobias Dick (German Cancer Research Center) for the roGFP2-Orp1 construct, Wenbiao Chen (Vanderbilt University) for zebrafish CRISPR reagents, Wolfgang Driever (University of Freiburg) for the nestin construct, and James Lister (Virginia Commonwealth University) for the otx2 and pax6a constructs.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Daniel M. Suter, Department of Biological Sciences, Purdue University, 915 West State Street, West Lafayette, IN 47907-2054. dsuter{at}purdue.edu
Other Version
- previous version (May 23, 2018).
- You are viewing the most recent version of this article.
Online Impact